|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 37.60 EUR | +1.08% |
|
+1.62% | -7.84% |
| 08-07 | SANOFI : Gets a Buy rating from Jefferies | ZD |
| 08-06 | Novavax raises annual revenue forecast as licensing bets offset weak vaccine demand | RE |
| Market Cap | 90.23B 104B 84.26B 77.29B 145B 9,927B 148B 989B 388B 4,976B 392B 383B 16,450B | P/E 2026 * |
12x | P/E 2027 * | 10.5x |
|---|---|---|---|---|---|
| Enterprise Value | 102B 117B 94.87B 87.03B 164B 11,178B 166B 1,113B 437B 5,603B 441B 431B 18,522B | EV / Sales 2026 * |
2.14x | EV / Sales 2027 * | 1.95x |
| Free-Float |
88.34% | Yield 2026 * |
5.65% | Yield 2027 * | 5.97% |
Last Transcript: Sanofi
| 1 day | +1.08% | ||
| 1 week | +1.62% | ||
| Current month | +1.62% | ||
| 1 month | +1.08% | ||
| 3 months | +2.17% | ||
| 6 months | -6.00% | ||
| Current year | -7.84% |
| 1 week | 36.8 |  | 38.4 |
| 1 month | 36 | | 39.8 |
| Current year | 35.6 | | 41.8 |
| 1 year | 35.6 | | 45 |
| 3 years | 35.6 | | 54.5 |
| 5 years | 35.6 | | 54.5 |
| 10 years | 31.4 | | 54.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 30/04/2026 | |
| Director of Finance/CFO | 64 | 31/03/2024 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 10/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 29/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 57 | 27/04/2020 |
Lise Kingo
BRD | Director/Board Member | 65 | 27/04/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.08% | +1.62% | - | - | 104B | |
| -0.52% | +3.21% | +89.52% | +127.32% | 1,057B | |
| +0.88% | +1.13% | +49.56% | +49.69% | 625B | |
| +0.89% | -1.95% | +24.23% | +64.44% | 435B | |
| +0.71% | +3.87% | +49.07% | +37.85% | 363B | |
| +0.64% | -0.49% | +33.94% | +40.01% | 296B | |
| +0.39% | -5.83% | +8.92% | +7.85% | 249B | |
| +1.51% | +6.69% | +42.58% | +57.57% | 222B | |
| +3.92% | -0.46% | -5.56% | -52.32% | 209B | |
| +1.80% | +2.30% | +11.56% | +66.35% | 165B | |
| Average | +1.13% | +0.87% | +33.76% | +44.31% | 402.31B | |
| Weighted average by Cap. | +0.67% | +1.22% | +48.72% | +64.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.51B 54.92B 44.36B 40.7B 76.55B 5,227B 77.76B 520B 204B 2,620B 206B 202B 8,661B | 50.61B 58.51B 47.26B 43.36B 81.55B 5,568B 82.84B 554B 218B 2,791B 220B 215B 9,227B |
| Net income | 7.94B 9.18B 7.42B 6.8B 12.8B 874B 13B 87.01B 34.15B 438B 34.47B 33.72B 1,448B | 9.27B 10.71B 8.65B 7.94B 14.93B 1,020B 15.17B 102B 39.85B 511B 40.23B 39.35B 1,689B |
| Net Debt | 11.37B 13.14B 10.62B 9.74B 18.32B 1,251B 18.61B 125B 48.88B 627B 49.35B 48.27B 2,072B | 8.22B 9.5B 7.67B 7.04B 13.24B 904B 13.45B 90.02B 35.33B 453B 35.67B 34.89B 1,498B |
| Date | Price | Change |
|---|---|---|
| 07/08/26 | €37.60 | +1.08% |
| 06/08/26 | €37.20 | +1.09% |
| 05/08/26 | €36.80 | 0.00% |
| 04/08/26 | €36.80 | -1.60% |
| 03/08/26 | €37.40 | +1.08% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
- SNW2 Stock
Select your edition
All financial news and data tailored to specific country editions
